Gerry McDougall, Chairman
PricewaterhouseCoopers LLP, Senior Partner
Mr. McDougall is Senior Partner at PricewaterhouseCoopers Health Sciences Practice, where he provides services to academic medical centers, bioscience companies, pharmaceutical companies, research universities, colleges, health systems, and other research organizations. His practice provides a broad range of research business and compliance services, including strategic and business planning, financial analysis, research compliance, clinical research operations improvement, and information systems implementation services. In addition, his practice provides support services to the entire research continuum, from grant-funded basic science research, to translational research and clinical trials, including a dedicated group focusing on Clinical Research Consulting services and Global oncology.
Walter M. Capone
GeneCentric Therapeutics, Chief Business Officer
Mr. Capone is a dynamic, accomplished, results-driven, global biotech/pharmaceutical leader with a twenty-year track record of accelerating breakthrough science, drug development and commercialization across the immunology, oncology and infectious disease therapeutic areas. In his senior executive roles in organizations ranging from seed-funded start-ups to leading, global biotech and pharma companies, Mr. Capone consistently established and led high performing teams to drive innovative product development, deliver entity-wide strategic and operational effectiveness, and achieve transformative corporate and business development results.
LOOPBACK Analytics, Chief Executive Officer
Neil Smiley is the founder and CEO of Loopback Analytics. Smiley started Loopback Analytics in 2009, after serving for 12 years as the founder and CEO of Phytel, a provider-led population health improvement company acquired by IBM Watson. Smiley started his professional career in management consulting with Accenture and later as a partner with EY, working with Fortune 1000 clients in the manufacturing, high tech, oil and gas, and transportation industries. Smiley serves as President of the Charles H. Hood Foundation, supporting child health research with leading institutions across New England and the Board of the Dartmouth Hood Museum of Art. Additionally, Smiley and his wife Judy are Auction Chairs for the Carson Leslie Foundation for pediatric cancer research. In 2013, Smiley was one of four finalists nominated for the Tech Titans Award for Emerging Technology Innovation in Dallas, and selected as one of the top 25 most influential persons in health care by the Dallas Business Journal. He serves as an active investor and mentor with Health Wildcatters, a health technology accelerator based in Dallas, working with emerging health care startups. Smiley’s passion is to build the kind of company where every employee feels connected to the mission of transforming the country’s health care system to benefit patients and providers. Smiley holds a bachelor’s degree in computer science from Dartmouth College.
Covera Ventures, Managing Director
Steve Coffey is a managing director of Covera Ventures and has more than 20 years of investment experience with companies at all stages of development. Steve leads the Firm’s investments in Alert Logic, CoreTrace, Hubspan, Innography, and Zumobi. Steve was a director or actively involved in such companies as Airspan (NASDAQ: AIRN), iTKO (acquired by CA), Metreos (acquired by Cisco), SiGe (acquired by Skyworks), SNAPin (acquired by Nuance), and Softricity (acquired by Microsoft).
Steve was previously president and managing director of Hunt Ventures and established the Austin office in 1999. Prior to Hunt Ventures, he was vice president of Hunt Financial Corporation, where he evaluated and managed investments in public equities, private equity and venture capital partnerships, and direct investments in both early stage technology companies and buyouts.
Earlier in his career, he worked as an associate at Davis Venture Partners, a private venture capital firm where he worked with both early and later-stage portfolio companies. He previously worked at EDS Corporation and Arthur Andersen, LLP. Steve has a BS from Oklahoma State University and an MBA with honors from The University of Texas.
The Beck Group, Co-Founder Board Director
Project Executive AT&T North TX, Directs $80M Construction Portfolio, Deacon Board Chairman, Covenant School Board – 5 years, University of Nebraska (Bachelor of Science Construction, College School of Engineering)
Co-Founder (Ex. Officio)
Development/Creative Director (Secured/leveraged/directed millions of dollars into childhood cancer research), Cancer Prevention and Research Institute of Texas (CPRIT), served on CPRIT’s Advisory Council for Childhood Cancers since 2010 (Invited to Speaker’s Bureau, Worked closely with Dr. Gilman, for The Carson Leslie Research Grants for Pediatric Brain Cancers, a $3.2M CLF/CPRIT collaboration, Advisory Council who influenced CPRIT to make childhood cancer a priority, portfolio increased from 3% to 11%, 2017 23% in childhood cancer research/prevention), Congressional Childhood Cancer Caucus, Washington, D.C. (Speaker at Inaugural Congressional Childhood Cancer Caucus, Founder/Chair Golden Toast, Annual Event Honoring Members of the Childhood Cancer Caucus, With other leaders in childhood cancer community, successfully lobbied congress and senate for policies and legislation changes research, 3 laws benefitting childhood cancer research)